Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 10/20 | 0.41 |
| ▸ | VNN1 | O95497 | 1/20 | 0.40 |
| ▸ | PIK3CA | P42336 | 3/20 | 0.39 |
| ▸ | MTOR | P42345 | 1/20 | 0.39 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.39 |
| ▸ | HTR1A | P08908 | 4/20 | 0.38 |
| ▸ | HTR7 | P34969 | 4/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.38 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30874812 | 0.79 | DPP4 (0.47) | DPP4PIK3CADPP9HTR1AHTR7 | |
| SCHEMBL30874948 | 0.79 | DPP4 (0.44) | DPP4VNN1DPP9HTR1AHTR7 | |
| SCHEMBL30874910 | 0.78 | CNR2 (0.39) | DPP4PIK3CACNR2PIK3CDPIK3CB | |
| SCHEMBL30874936 | 0.77 | DPP4 (0.44) | DPP4PIK3CADPP9HTR1AHTR7 | |
| SCHEMBL30874862 | 0.75 | CYP19A1 (0.47) | DPP4VNN1DPP9HTR1AHTR7 | |
| SCHEMBL30874847 | 0.74 | DPP4 (0.47) | DPP4DPP9HTR1AHTR7 | |
| SCHEMBL30874909 | 0.74 | VNN1 (0.47) | DPP4VNN1DPP9HTR1AHTR7 | |
| SCHEMBL13570397 | 0.74 | DPP4 (0.49) | DPP4VNN1HTR1AHTR7 | |
| SCHEMBL30874840 | 0.74 | DPP4 (0.49) | DPP4VNN1HTR1AHTR7 | |
| SCHEMBL30874915 | 0.74 | DPP4 (0.45) | DPP4VNN1DPP9HTR1AHTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117956985-A | Inhibitors of glycogen synthase 1 (GYS 1) and methods of use thereof | 梅兹治疗公司 | 2024-04-30 | — | — | CN | disclosed |